Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Generex nets $4.9mm via registered direct offering

Executive Summary

Generex Biotechnology (oral drug delivery) netted $4.9mm through a registered direct offering of 15.15mm common shares at $0.33 each (a 21% discount) to several accredited investors. Rodman & Renshaw was the placement agent.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Private Investment in Public Biotech

Related Companies

Advertisement
UsernamePublicRestriction

Register